Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Forum on Immunopathological Diseases and Therapeutics
SJR: 0.164 SNIP: 0.041 CiteScore™: 0.18

ISSN Печать: 2151-8017
ISSN Онлайн: 2151-8025

Archives: Volume 1, 2010 to Volume 7, 2016

Forum on Immunopathological Diseases and Therapeutics

DOI: 10.1615/ForumImmunDisTher.2012006186
pages 155-167

Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors

Naveena B. Janakiram
Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PCS Oklahoma Cancer Center, University of Oklahoma Health Sciences, Oklahoma City, Oklahoma
Chinthalapally V. Rao
Center for Cancer Prevention and Drug Development, Medical Oncology, Department of Medicine, PCS Oklahoma Cancer Center, University of Oklahoma Health Sciences, Oklahoma City, Oklahoma

Краткое описание

Nitric oxide (NO) is a short-lived pleiotropic regulator and is required for numerous pathophysiological functions, including macrophage-mediated immunity and cancer. It is a highly reactive free radical produced from L-arginine by different isoforms of NO synthases (NOSs). Sustained induction of inducible NOS (iNOS) during chronic inflammatory conditions leads to the formation of reactive intermediates of NO, which are mutagenic and cause DNA damage or impairment of DNA repair, alter cell signaling, and promote proinflammatory and angiogenic properties of the cell, thus contributing to carcinogenesis. Besides its well-established role in inflammation, increased expression of iNOS has been observed in colorectal tumors and other cancers. NO-related signaling pathways involved in colon tumorigenesis seem to progress through stimulation of proinflammatory cytokines and via posttranslational protein modifications of important antiapoptotic molecules in the tumors. NO can stimulate and enhance tumor cell proliferation by promoting invasive, angiogenic, and migratory activities. In contrast, studies also suggest that high levels of NO may be protective against tumor growth by inducing tumor cell death. However, a number of in vitro studies and particularly experimental animal data support the notion that NO and its reactive metabolite peroxynitrite stimulate cyclooxygenase-2 activity, leading to generation of prostaglandins that enhance tumor growth. These prostaglandins further augment tumor promotion and invasive properties of tumor cells. Hence, selective inhibitors of iNOS and combination strategies to inhibit both iNOS and cyclooxygenase-2 may have a preventive role in colon cancer.

Articles with similar content:

Inducible Nitric Oxide Synthase/ Cyclooxygenase-2 Pathway Interaction: A Good Molecular Target for Cancer Treatment
Forum on Immunopathological Diseases and Therapeutics, Vol.1, 2010, issue 3
Emanuela Masini, Fabio Cianchi
Cell Adhesion Molecules: Selectins and Integrins
Critical Reviews™ in Immunology, Vol.19, 1999, issue 5-6
Francisco Sanchez-Madrid, Roberto González-Amaro
Plasma-Activated Medium Selectively Kills Glioblastoma Brain Tumor Cells by Down-Regulating a Survival Signaling Molecule, AKT Kinase
Plasma Medicine, Vol.1, 2011, issue 3-4
Masaru Hori, Hiromasa Tanaka, Hiroaki Kajiyama, Kenji Ishikawa, Masaaki Mizuno, Hiroyuki Kano, Kae Nakamura, Fumitaka Kikkawa
Roles of Smad3 in TGF-β Signaling During Carcinogenesis
Critical Reviews™ in Eukaryotic Gene Expression, Vol.17, 2007, issue 4
Caroline Millet, Ying E. Zhang
Effect of Atmospheric-Pressure Plasmas on Drug Resistant Melanoma: The Challenges of Translating In vitro Outcomes into Animal Models
Plasma Medicine, Vol.6, 2016, issue 1
Anthony Rowe, Musarat Ishaq, Kostya (Ken) Ostrikov, Kateryna Bazaka, Mark Krockenberger , Margaret D. M. Evans